Back

Optimal strategy for antiplatelet therapy after endovascular revascularization in patients with lower extremity artery disease

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Peripheral artery disease: tackling the burden and improving outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jongkwon Seo

Inje University Sanggye Paik Hospital, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Nationwide trends and projections of peripheral arterial disease among Danish adults
Mrs M. Soegaard (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Evaluation of Takayasu's arteritis activity by ultrasound localization microscopy
Doctor G. Goudot (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Elevated Lipoprotein(a) levels increase Major Adverse Limb Event
Doctor A. Guedon (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Evaluation of the benefit of rivaroxaban on VOYAGER PAD primary composite of limb, heart and brain outcomes using the global rank and win ratio methods
Doctor M. Bonaca (Aurora, US)
Abstract Slides Video
Presentation thumbnail
Impact of poor below-the-knee run-off on stent failure of femoro-popliteal arteries in healthy swine model.
Doctor N. Nakamura (Isehara, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: tackling the burden and improving outcomes
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
thumbnail
Congress Presentation
Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients
thumbnail
Congress Presentation
Duration of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) for bifurcation lesions: insights from the ULTRA-BIFURCAT registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources